Disc Medicine Announces Oral Presentation of Data from RALLY-MF Phase 2 Trial of DISC-0974 in Patients with Myelofibrosis and Anemia at the American Society of Clinical Oncology (ASCO) Annual Meeting
Disc Medicine announced that it will present new data from the RALLY-MF Phase 2 trial of DISC-0974, an investigational treatment for anemia in myelofibrosis patients, at the American Society of Clinical Oncology Annual Meeting in June 2026. Initial trial results showed unprecedented anemia response rates in a hard-to-treat population, with updated …